Reply to “Evaluation of nanomedicines: stick to the basics”

  • Subscribe to Nature Reviews Materials for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).

  2. 2.

    Correspondence to the editor. Nat. Rev. Mater. (2016).

  3. 3.

    , , , & Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J. Control. Release 232, 255–264 (2016).

  4. 4.

    [No authors listed.] A billion dollar punt. Nat. Biotechnol. 24, 1453 (2006).

  5. 5.

    Merck writes off RNAi, punts Sirna to Alnylam for $175M. FierceBiotech (updated 4 Jul 2016).

  6. 6.

    , & Goodman & Gilman's the Pharmacological Basis of Therapeutics (McGraw-Hill Medical, 2011).

  7. 7.

    et al. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc. Natl Acad. Sci. USA 113, E1142–E1151 (2016).

Download references

Author information


  1. Stefan Wilhelm, Anthony J. Tavares and Warren C. W. Chan are at the Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College St, Toronto, Ontario, M5S 3G9, Canada.

    • Stefan Wilhelm
    • , Anthony J. Tavares
    •  & Warren C. W. Chan
  2. Warren C. W. Chan is at the Donnelly Center for Cellular and Biomolecular Research, University of Toronto, 160 College St, Toronto, Ontario, M5S 3E1, Canada.

    • Warren C. W. Chan
  3. Departments of Chemistry, Materials Science and Engineering, and Chemical Engineering, University of Toronto, 164 College St, Toronto, Ontario, M5S 3G9, Canada.

    • Warren C. W. Chan


  1. Search for Stefan Wilhelm in:

  2. Search for Anthony J. Tavares in:

  3. Search for Warren C. W. Chan in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Warren C. W. Chan.

Supplementary information

PDF files

  1. 1.

    Supplementary information S1–S3 (box, figure, table)

    Supplementary information